Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with Novo Nordisk on Most-Favoured-Nation drug pricing and tariff exemption

Description

On 6 November 2025, the U.S. Administration announced an agreement with Novo Nordisk. Under the agreement, Novo Nordisk committed to make investments in manufacturing in the United States. In return, ...

Sign in to see full description

Intervention Details

Intervention Type

FDI: Financial incentive

MAST Chapter

FDI measures

Implementation date

No implementation date

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 3 products

Threads

See all

This intervention is not part of any Thread yet.